19 February 2009
PORTFOLIO COMPANY INVESTMENT
The Board of International Biotechnology Trust plc (the 'Company') notes the following follow on investment in unquoted portfolio company TransEnterix Inc.
On 18 February 2009, the Company invested £451,000 (US$642,000) into TransEnterix, which reached the milestones necessary to trigger this second round of funding. TransEnterix is based in North Carolina in the US, and this investment brings the Company's total invested cost in this investee company to £882,000, with a current value of £1.1m. TransEnterix is developing a surgical platform that provides all the benefits of a multi-port laparoscopic surgical approach while retaining a single port of entry through a natural body orifice or via the umbilicus.
Enquiries:
Kate Bingham/David Pinniger
SV Life Sciences Managers LLP
Investment Manager Tel: 020 7412 7070
Louise Richard
Schroder Investment Management Limited Tel: 020 7658 6501